Post-Marketing Surveillance Study Emselex.
Phase of Trial: Phase IV
Latest Information Update: 29 Aug 2016
At a glance
- Drugs Darifenacin (Primary)
- Indications Overactive bladder
- Focus Adverse reactions; Therapeutic Use
- Sponsors Bayer
- 06 Jul 2012 New source identified and integrated (German Clinical Trials Register: DRKS00003990).
- 16 Feb 2009 Additional location (Germany) identified as reported by ClinicalTrials.gov, last updated 16 Feb 2009.
- 25 Nov 2008 New trial record.